Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

Similar articles for PubMed (Select 23873933)

1.

Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.

Maaty WS, Lord CI, Gripentrog JM, Riesselman M, Keren-Aviram G, Liu T, Dratz EA, Bothner B, Jesaitis AJ.

J Biol Chem. 2013 Sep 20;288(38):27042-58. doi: 10.1074/jbc.M113.484113. Epub 2013 Jul 19.

2.
3.

A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead.

Winther M, Gabl M, Welin A, Dahlgren C, Forsman H.

FEBS Lett. 2015 Jun 9. pii: S0014-5793(15)00451-2. doi: 10.1016/j.febslet.2015.05.050. [Epub ahead of print]

PMID:
26071379
4.
5.

Inhibition of Human Neutrophil Responses by the Essential Oil of Artemisia kotuchovii and Its Constituents.

Schepetkin IA, Kushnarenko SV, Özek G, Kirpotina LN, Utegenova GA, Kotukhov YA, Danilova AN, Özek T, Başer KH, Quinn MT.

J Agric Food Chem. 2015 May 27;63(20):4999-5007. doi: 10.1021/acs.jafc.5b01307. Epub 2015 May 19.

PMID:
25959257
6.

Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.

Yousif AM, Minopoli M, Bifulco K, Ingangi V, Di Carluccio G, Merlino F, Motti ML, Grieco P, Carriero MV.

PLoS One. 2015 May 4;10(5):e0126172. doi: 10.1371/journal.pone.0126172. eCollection 2015.

7.

Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.

Rossi FW, Napolitano F, Pesapane A, Mascolo M, Staibano S, Matucci-Cerinic M, Guiducci S, Ragno P, di Spigna G, Postiglione L, Marone G, Montuori N, de Paulis A.

J Immunol. 2015 Jun 1;194(11):5161-73. doi: 10.4049/jimmunol.1402819. Epub 2015 Apr 27.

PMID:
25917089
8.

Microenvironment involved in FPR1 expression by human glioblastomas.

Boer JC, van Marion DM, Joseph JV, Kliphuis NM, Timmer-Bosscha H, van Strijp JA, de Vries EG, den Dunnen WF, Kruyt FA, Walenkamp AM.

J Neurooncol. 2015 May;123(1):53-63. doi: 10.1007/s11060-015-1777-2. Epub 2015 Apr 19.

9.

Non-peptide ligand binding to the formyl peptide receptor FPR2-A comparison to peptide ligand binding modes.

Stepniewski TM, Filipek S.

Bioorg Med Chem. 2015 Jul 15;23(14):4072-81. doi: 10.1016/j.bmc.2015.03.062. Epub 2015 Mar 28.

PMID:
25882522
10.

Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex.

Buss NA, Gavins FN, Cover PO, Terron A, Buckingham JC.

FASEB J. 2015 Jul;29(7):2930-42. doi: 10.1096/fj.14-268375. Epub 2015 Mar 27.

PMID:
25818588
11.

The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation.

Dorward DA, Lucas CD, Chapman GB, Haslett C, Dhaliwal K, Rossi AG.

Am J Pathol. 2015 May;185(5):1172-84. doi: 10.1016/j.ajpath.2015.01.020. Epub 2015 Mar 17. Review.

PMID:
25791526
12.

Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.

Kretschmer D, Rautenberg M, Linke D, Peschel A.

J Leukoc Biol. 2015 Apr;97(4):689-97. doi: 10.1189/jlb.2A0514-275R. Epub 2015 Feb 27.

PMID:
25724390
13.

Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.

Charest-Morin X, Roy C, Fernandes MJ, Marceau F.

Int Immunopharmacol. 2015 Mar;25(1):229-34. doi: 10.1016/j.intimp.2015.01.029. Epub 2015 Feb 10.

PMID:
25681283
14.

Adaptive evolution of formyl peptide receptors in mammals.

Muto Y, Guindon S, Umemura T, Kőhidai L, Ueda H.

J Mol Evol. 2015 Feb;80(2):130-41. doi: 10.1007/s00239-015-9666-z. Epub 2015 Jan 28.

PMID:
25627928
15.

Recognition of bacterial signal peptides by mammalian formyl peptide receptors: a new mechanism for sensing pathogens.

Bufe B, Schumann T, Kappl R, Bogeski I, Kummerow C, Podgórska M, Smola S, Hoth M, Zufall F.

J Biol Chem. 2015 Mar 20;290(12):7369-87. doi: 10.1074/jbc.M114.626747. Epub 2015 Jan 20.

PMID:
25605714
16.

Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamides as selective agonists of human formyl-peptide receptor 2.

Lacivita E, Schepetkin IA, Stama ML, Kirpotina LN, Colabufo NA, Perrone R, Khlebnikov AI, Quinn MT, Leopoldo M.

Bioorg Med Chem. 2015 Jul 15;23(14):3913-24. doi: 10.1016/j.bmc.2014.12.007. Epub 2014 Dec 13.

PMID:
25549897
17.

Human neutrophils are activated by a peptide fragment of Clostridium difficile toxin B presumably via formyl peptide receptor.

Goy SD, Olling A, Neumann D, Pich A, Gerhard R.

Cell Microbiol. 2015 Jun;17(6):893-909. doi: 10.1111/cmi.12410. Epub 2015 Jan 26.

PMID:
25529763
18.

Formyl peptide receptor as a novel therapeutic target for anxiety-related disorders.

Gallo I, Rattazzi L, Piras G, Gobbetti T, Panza E, Perretti M, Dalley JW, D'Acquisto F.

PLoS One. 2014 Dec 17;9(12):e114626. doi: 10.1371/journal.pone.0114626. eCollection 2014.

19.

The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.

Skovbakke SL, Heegaard PM, Larsen CJ, Franzyk H, Forsman H, Dahlgren C.

Biochem Pharmacol. 2015 Jan 15;93(2):182-95. doi: 10.1016/j.bcp.2014.11.004. Epub 2014 Nov 14.

PMID:
25462815
20.

Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

Schepetkin IA, Kirpotina LN, Khlebnikov AI, Cheng N, Ye RD, Quinn MT.

Biochem Pharmacol. 2014 Dec 15;92(4):627-41. doi: 10.1016/j.bcp.2014.09.027. Epub 2014 Oct 17.

PMID:
25450672
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk